Drug information for ATELVIA

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
TABLET, DELAYED RELEASE; ORAL	35MG	Prescription	(Reference Drug)	RISEDRONATE SODIUM	risedronic acid	WARNER CHILCOTT	22560 2012-03-22 Label 2012-03-22 Label 2011-12-20 Other Important Information from FDA 2011-08-24 Letter 2011-03-21 Review 2011-03-21 Summary Review 2011-02-15 Letter 2011-02-15 Letter 2011-02-02 Other 2011-02-01 Medication Guide 2010-10-19 Letter 2010-10-18 Label

Drug Adverse Effects information for ATELVIA

Role code	Indications	Reaction	# Reports
PS	BONE DISORDER	ABDOMINAL DISTENSION	1
PS	BONE DISORDER	GASTRIC DISORDER	1
PS	BONE SCAN	ABDOMINAL DISCOMFORT	1
PS	BONE SCAN	ARTHRALGIA	1
PS	BONE SCAN	ASTHENIA	1
PS	BONE SCAN	BLOOD GLUCOSE INCREASED	1
PS	BONE SCAN	HEADACHE	1
PS	BONE SCAN	PAIN	1
PS	BONE SCAN	RENAL PAIN	1
PS	BONE SCAN	TENSION	1
PS	OSTEOPENIA	DIARRHOEA	1
PS	OSTEOPENIA	INFLUENZA LIKE ILLNESS	1
PS	OSTEOPENIA	VOMITING	1
PS	OSTEOPOROSIS	ABDOMINAL DISCOMFORT	1
PS	OSTEOPOROSIS	ABDOMINAL PAIN UPPER	1
PS	OSTEOPOROSIS	ARTHRALGIA	3
PS	OSTEOPOROSIS	ASTHENIA	2
PS	OSTEOPOROSIS	BLOOD GLUCOSE INCREASED	2
PS	OSTEOPOROSIS	CHILLS	1
PS	OSTEOPOROSIS	EYE PAIN	1
PS	OSTEOPOROSIS	GASTRITIS	1
PS	OSTEOPOROSIS	HEADACHE	3
PS	OSTEOPOROSIS	INFLUENZA LIKE ILLNESS	1
PS	OSTEOPOROSIS	NAUSEA	1
PS	OSTEOPOROSIS	PAIN	2
PS	OSTEOPOROSIS	PYREXIA	1
PS	OSTEOPOROSIS	RENAL PAIN	2
PS	OSTEOPOROSIS	TENSION	2
PS	OSTEOPOROSIS	URINARY TRACT INFECTION	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	ARTHRALGIA	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	INITIAL INSOMNIA	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	MUSCULOSKELETAL STIFFNESS	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	PHOTOPHOBIA	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	PHOTOPSIA	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	RESTLESSNESS	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	VISION BLURRED	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	VISUAL ACUITY REDUCED	1
PS	OSTEOPOROSIS POSTMENOPAUSAL	VITREOUS FLOATERS	1
SS	CHRONIC MYELOID LEUKAEMIA	PAIN	1
SS	CHRONIC MYELOID LEUKAEMIA	PELVIC FRACTURE	1
SS	CHRONIC MYELOID LEUKAEMIA	PYREXIA	1

Ads by Google